Ashfield Pharmacovigilance, part of UDG Healthcare, will be exhibiting at the DIA Pharmacovigilance and Risk Management Strategies Conference, which will take place January 22-24, 2018 in Washington, DC at the Omni Shoreham Hotel.
DIA’s Pharmacovigilance and Risk Management Strategies Conference provides the strongest context, background, updates, new developments, and future direction for regulations and guidance on safety, pharmacovigilance, and risk management strategies that cannot be found in any other meeting.
This year’s meeting will take an in-depth look at global harmonization of ICH E19, addressing optimization of safety data collection. It will include insights and forward-thinking approaches to pharmacovigilance and risk management to ensure the safety of existing as well as advanced new therapies as these enter development and the post-market setting. Projects applying cutting edge technologies like machine learning/artificial intelligence to manage large volumes of potential safety data will also be examined.
Come see us in booth #33 in the exhibition area.
You can learn more about at DIA Pharmacovigilance and Risk Management Strategies Conference and register here.